Participation List (30/10/25) – CURRENTLY BEING UPDATED
Service Specification – Enhanced Pharmaceutical Care Services v3 June 2024
SOP for Primary Care Supply of Enzalutamide for the Treatment of Prostate Cancer in Uro-Oncology Clinics (GGC)*
* PLEASE NOTE – SOP IS CURRENTLY UNDER REVISION (as of December 2022)
ORDER FORM
| BRAND NAME | GENERIC NAME | APPROVED SUPPLIER |
| Xtandi® (PLEASE CLICK) | Enzalutamide | ASTELLAS All orders must be placed with the manufacturer (Astellas) directly by contacting their Customer Services department either by telephone or email. Telephone: 0203 879 8721 Email: ukcustomerservices@astellas.com If problems in accessing the medicine via this supply route cannot be resolved through direct dialogue with Astellas, contact the Health Board. Do not purchase from any other supply route without the approval of the Health Board. |
OUT OF AREA HEALTH BOARD PARTICIPATION LISTS
Responsible Person: Bridie McCallum
Last Updated: 01/07/26